Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers

Clinical trial NCT00095862 · TERMINATED

Trial details

NCT number: NCT00095862
Sponsor: Wiseman Research Initiatives LLC
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2004-11-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.